These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29766377)

  • 21. Pharmacological treatment options for cryopyrin-associated periodic syndromes.
    Landmann EC; Walker UA
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):855-864. PubMed ID: 28586272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CINCA syndrome in an infant presenting with hydrocephalus.
    Turel O; Goknar N; Uzuner S; Kasapcopur O; Cuisset L
    Int J Rheum Dis; 2014 Mar; 17(3):346-8. PubMed ID: 24618115
    [No Abstract]   [Full Text] [Related]  

  • 23. Cryopyrin-associated periodic syndrome in early childhood can be successfully treated with interleukin-1 blockades.
    Eskola V; Pohjankoski H; Kröger L; Aalto K; Latva K; Korppi M
    Acta Paediatr; 2018 Apr; 107(4):577-580. PubMed ID: 29331074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [CINCA syndrome: a rare cause of papilledema. The case of homozygous twins].
    Carzoli A; Maalouf T; Henckes O; Lemelle I; George JL; Angioi K
    J Fr Ophtalmol; 2010 Jan; 33(1):36-9. PubMed ID: 20005004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurologic manifestations of the cryopyrin-associated periodic syndrome.
    Kitley JL; Lachmann HJ; Pinto A; Ginsberg L
    Neurology; 2010 Apr; 74(16):1267-70. PubMed ID: 20404307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and genetic characterization of Italian patients affected by CINCA syndrome.
    Caroli F; Pontillo A; D'Osualdo A; Travan L; Ceccherini I; Crovella S; Alessio M; Stabile A; Gattorno M; Tommasini A; Martini A; Lepore L
    Rheumatology (Oxford); 2007 Mar; 46(3):473-8. PubMed ID: 16920754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical features of CINCA syndrome: effects and problems of IL-1Ra].
    Sugiura H; Matsubayashi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Apr; 30(2):108-13. PubMed ID: 17473513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early progression of atherosclerosis in children with chronic infantile neurological cutaneous and articular syndrome.
    Yamamura K; Takada H; Uike K; Nakashima Y; Hirata Y; Nagata H; Takimoto T; Ishimura M; Morihana E; Ohga S; Hara T
    Rheumatology (Oxford); 2014 Oct; 53(10):1783-7. PubMed ID: 24821850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrocephalus in CINCA syndrome treated with anakinra.
    Rigante D; Ansuini V; Caldarelli M; Bertoni B; La Torraca I; Stabile A
    Childs Nerv Syst; 2006 Apr; 22(4):334-7. PubMed ID: 16525848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Good response to IL-1beta blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies.
    Hedrich CM; Fiebig B; Sallmann S; Bruck N; Hahn G; Roesler J; Roesen-Wolff A; Heubner G; Gahr M
    Scand J Rheumatol; 2008; 37(5):385-9. PubMed ID: 18609262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic Infantile Neurological Cutaneous and Articular (CINCA) syndrome: a review.
    Finetti M; Omenetti A; Federici S; Caorsi R; Gattorno M
    Orphanet J Rare Dis; 2016 Dec; 11(1):167. PubMed ID: 27927236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term treatment with anakinra and canakinumab resolves patellar subchondral erosion in neonatal-onset multisystem inflammatory disease.
    Leone A; Manna R; Verrecchia E; Cipullo M; Rigante D
    Reumatismo; 2019 Apr; 71(1):53-55. PubMed ID: 30932446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CAPS--pathogenesis, presentation and treatment of an autoinflammatory disease.
    Kuemmerle-Deschner JB
    Semin Immunopathol; 2015 Jul; 37(4):377-85. PubMed ID: 25963520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome.
    Kuemmerle-Deschner JB; Hofer F; Endres T; Kortus-Goetze B; Blank N; Weißbarth-Riedel E; Schuetz C; Kallinich T; Krause K; Rietschel C; Horneff G; Benseler SM
    Rheumatology (Oxford); 2016 Apr; 55(4):689-96. PubMed ID: 26667214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Skin ulcerations due to CINCA syndrome and its successful treatment with prostaglandin E
    Brochhausen C; Babel M; Schmitt VH; Grevenstein D; Schreml S; Meyer-Scholten C; Klaus G
    Z Rheumatol; 2018 Sep; 77(7):633-636. PubMed ID: 30066026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased quality of life and societal impact of cryopyrin-associated periodic syndrome treated with canakinumab: a questionnaire based cohort study.
    Mulders-Manders CM; Kanters TA; van Daele PLA; Hoppenreijs E; Legger GE; van Laar JAM; Simon A; Hakkaart-van Roijen L
    Orphanet J Rare Dis; 2018 Apr; 13(1):59. PubMed ID: 29678136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism underlying mendelian inherited diseases.
    Aróstegui JI; Lopez Saldaña MD; Pascal M; Clemente D; Aymerich M; Balaguer F; Goel A; Fournier del Castillo C; Rius J; Plaza S; López Robledillo JC; Juan M; Ibañez M; Yagüe J
    Arthritis Rheum; 2010 Apr; 62(4):1158-66. PubMed ID: 20131270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoinflammatory retinopathy in chronic infantile neurological cutaneous and articular (CINCA) syndrome.
    Tran T; Moloney T; Adams MK; Shah SP
    J AAPOS; 2016 Aug; 20(4):365-8. PubMed ID: 27320017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor-alpha blockade ameliorates inflammatory response in two children with chronic infantile neurological, cutaneous and articular syndrome.
    Luo XY; Chen AW; Cai JH; Fang J; Wang H
    J Dermatol; 2020 Aug; 47(8):903-906. PubMed ID: 32490544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectrum of the neurologic manifestations in childhood-onset cryopyrin-associated periodic syndrome.
    Kilic H; Sahin S; Duman C; Adrovic A; Barut K; Turanli ET; Yildirim SR; Kizilkilic O; Kasapcopur O; Saltik S
    Eur J Paediatr Neurol; 2019 May; 23(3):466-472. PubMed ID: 30967326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.